- Home
- Companies
- east timor
- develop diagnostic
Refine by
Develop Diagnostic Suppliers Serving East Timor
123 companies found
based inSongpa-gu, SOUTH KOREA
With over 20-years’ experience in nucleic acid extraction reagents, GeneAll Biotechnology will work with you to suit your specific needs and pursue becoming a leading molecular diagnostic solution provider. GeneAll Biotechnology has been developed ...
based inGyeonggi-do, SOUTH KOREA
Established in 1966 as an IVD manufacturer. Annual revenue increased year to year. YD Diagnostics has developed new IVD products and persistently improved their quality by our own high technology and know-how. R&D Center has been developing IVD ...
based inSuwon-si, SOUTH KOREA
SD BIOSENSOR is a professional in-vitro diagnostics company with aims of contributing to higher life quality by diagnosing illnesses accurately and quickly. SD BIOSENSOR is researching and developing quick diagnostics, immunodiagnostics, molecular ...
based inPoway, CALIFORNIA (USA)
Diazyme uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme's products include test kits for diagnosis of cardiovascular disease, liver ...
based inBuffalo, NEW YORK (USA)
At ZeptoMetrix, we’ve always understood that research success requires a team approach. That is why our mission to be “a partner to our customers” remains the focal point as we, together with our industrial partners, endeavor to change the global ...
The Zika Antibody Control Pack consists of onevial each ofIgG, IgM and negative antibody controls. The IgG and IgM controls contain anti-Zika NS1 mouse monoclonal antibody conjugated to purified human IgG or IgM, respectively. All controls are ...
based inPalombara Sabina, ITALY
DAS company is based in Palombara Sabina – Italy since 1977, starts with propensity to the innovation in the electro-medical sector, beginning with pediatrics, by proposing alternative equipment with competitive solutions. Later on DAS acquires ...
based inHouston, TEXAS (USA)
Azure Biotech Inc is a global biotechnology company that specializes in research & development, as well as the production and sales of diagnostic reagents, POCT analyzers and biological materials. Azure Biotech is also heavily involved in research ...
based inBoston, MASSACHUSETTS (USA)
Sherlock Biosciences is dedicated to providing global access to the simplest and most accurate tests that empower individuals to control their own healthcare. Through its Engineering Biology platforms, the company is developing applications of ...
based inNedlands, Perth, AUSTRALIA
Proteomics International is a pioneering medical technology company operating at the forefront of predictive diagnostics and bio-analytical services. The Company specialises in the area of proteomics – the industrial scale study of the structure and ...
based inVienna, AUSTRIA
We are specialized in biomarker development using blood-circulating microRNAs – evolutionary conserved regulators of gene expression and cell/tissue function. We develop diagnostic algorithms (“signatures”) based on the logic combination of microRNA ...
based inLa Jolla, CALIFORNIA (USA)
Liferiver is a leading PCR-based molecular diagnostics solution provider, developing, manufacturing & marketing real time PCR diagnostic kits as well as instruments. We offer over 400 testing kits covering most infectious diseases, genetic diseases, ...
based inSeongnam-si, SOUTH KOREA
OPTOLANE is a semiconductor based In-Vitro diagnostic platform company that develops diagnostic systems with high sensitivity. The company is specialized in “Digital Real-Time PCR” system which can operate as both Real-Time PCR and Digital PCR. This ...
based inCrumlin, UNITED KINGDOM
A global market leader within the in vitro diagnostics industry, Randox Laboratories develops innovative diagnostic solutions for hospitals, clinical, research and molecular labs, food testing, forensic toxicology, veterinary labs and life sciences. ...
based inSongpa-gu, SOUTH KOREA
Seegene tirelessly pursues innovation and takes on new challenges to build a better future for humanity. Seegene has developed instruments for molecular diagnostics based on OEM partnership. In addition to that, Seegene has developed its own ...
based inValladolid, SPAIN
Founded in 2010, AMADIX is a leading molecular diagnostics company, focused on liquid biopsy, developing innovative diagnostic tests for early cancer detection in blood. Our mission is to extend people’s lives by developing disruptive technologies ...
based inBerlin, GERMANY
We revolutionize the way of cancer diagnostics using our unique, proprietary DNA methylation biomarker technology. Epigenomics develops and commercializes patient-friendly, blood-based diagnostic tests across multiple cancer indications with high ...
based inIrvine, CALIFORNIA (USA)
Konan Medical develops and distributes innovative ophthalmic diagnostic devices that help clinicians diagnose and manage vision- threatening or potentially life-threatening disorders. Konan Medical USA is an ISO 13485, FDA Registered, MDSAP ...
based inDurham,, NORTH CAROLINA (USA)
Founded in 1998, Cancer Diagnostics, Inc. (CDI) is a leading developer and manufacturer of histology, cytology, surgical pathology and immunohistochemistry diagnostic supplies. CDI developed the first commercially available 7-dye color kit for ...
based inGolestan Town, IRAN
Pishtaz Teb Zaman Diagnostics, started its research, development, and marketing activities in 1998, and rapidly grew to be an international brand specialized in 'In-Vitro Diagnostics Medical Devices and Clinical research'. Our range of products are ...
based inNottingham, UNITED KINGDOM
Oncimmune is a leading immuno diagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Our growing range of diagnostic products can detect early-stage cancer and our service-based ...
Oncimmune’s proprietary biomarker discovery engine, which is leveraged in our ImmunoINSIGHTS services to discover and validate novel biomarkers that can help stratify patients in multiple cancer indications and with different autoimmune ...
